N-naphthoylglycines as aldose reductase inhibitors

Details N-naphthoylglycines as aldose reductase inhibitors N-naphthoylglycines as aldose reductase inhibitors

1989-08-22

1990-10-09

Shippen, Michael L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acid esters

560 10, 562427, 562444, 564 74, C07C26100

Patent

active

049622242

ABSTRACT:
Disclosed herein are N-naphthoylglycines and methods of their preparation. The N-naphthoylglycines are novel aldose reductase inhibitors useful for the treatment or prevention of diabetic complications.

REFERENCES:
patent: 4391816 (1983-07-01), Sestanj
patent: 4391825 (1983-07-01), Bellini
patent: 4439617 (1984-03-01), Sestanj
patent: 4447452 (1984-05-01), Sestanj
patent: 4568693 (1986-02-01), Sestanj
patent: 4600724 (1986-07-01), Sestanj
patent: 4672058 (1987-06-01), Bellini
patent: 4672059 (1987-06-01), Sestanj
patent: 4699993 (1987-10-01), Brandt
patent: 4785018 (1988-11-01), Murase

Affiliated with

Also associated with

Rating

N-naphthoylglycines as aldose reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-naphthoylglycines as aldose reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-naphthoylglycines as aldose reductase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-974708